Invention Grant
- Patent Title: Combination of TIM-4 antagonist and PD-1 antagonist and methods of use
-
Application No.: US16314732Application Date: 2017-07-05
-
Publication No.: US11306143B2Publication Date: 2022-04-19
- Inventor: Sean E. Doyle , Mark J. Selby , Eric Chadwick
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard; Cynthia L. Kanik
- International Application: PCT/US2017/040665 WO 20170705
- International Announcement: WO2018/009507 WO 20180111
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; A61K9/00 ; A61K39/00
Abstract:
Provided are methods and compositions for treating cancer using an effective amount of a PD-1 antagonist (e.g., an antibody) in combination with a TIM-4 antagonist (e.g., an antibody).
Public/Granted literature
- US20190389950A1 COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE Public/Granted day:2019-12-26
Information query
